Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Gabow

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of the American Society of Nephrology : JASN|June 1, 1995
Causes of death in autosomal dominant polycystic kidney diseaseG M Fick, A M Johnson, W S Hammond, et al.
Annals of Internal Medicine|May 1, 1977
Furosemide-induced reduction in ionized calcium in hypoparathyroid patientsP A Gabow, T J Hanson, M M Popovtzer, et al.
Kidney International|September 1, 1986
A new method for studying human polycystic kidney disease epithelia in cultureP D Wilson, R W Schrier, R D Breckon, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1994
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney diseaseA B Chapman, A M Johnson, P A Gabow, et al.
Archives of Internal Medicine|October 1, 1983
The role of alcohol in new-onset atrial fibrillationS R Lowenstein, P A Gabow, J Cramer, et al.
The Western Journal of Medicine|October 1, 1995
Improving identification of and intervention for alcoholismP S Mehler, M D McClellan, D Lezotte, et al.
Kidney International|May 1, 1990
Intra- and extracellular proteins in human normal and polycystic kidney epithelial cellsY Granot, V Van Putten, J Przekwas, et al.
Journal of Medical Genetics|November 1, 1990
Exclusion of autosomal dominant polycystic kidney disease type II (ADPKD2) from 160 cM of chromosome 1S Kumar, W J Kimberling, P A Gabow, et al.
Annals of Internal Medicine|June 1, 1981
Syndromes of toluene sniffing in adultsH Z Streicher, P A Gabow, A H Moss, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 16, 1999
Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal diseaseC K Sharp, B E Zeligman, A M Johnson, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of the American Society of Nephrology : JASN|June 1, 1995
Causes of death in autosomal dominant polycystic kidney diseaseG M Fick, A M Johnson, W S Hammond, et al.
Annals of Internal Medicine|May 1, 1977
Furosemide-induced reduction in ionized calcium in hypoparathyroid patientsP A Gabow, T J Hanson, M M Popovtzer, et al.
Kidney International|September 1, 1986
A new method for studying human polycystic kidney disease epithelia in cultureP D Wilson, R W Schrier, R D Breckon, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1994
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney diseaseA B Chapman, A M Johnson, P A Gabow, et al.
Archives of Internal Medicine|October 1, 1983
The role of alcohol in new-onset atrial fibrillationS R Lowenstein, P A Gabow, J Cramer, et al.
The Western Journal of Medicine|October 1, 1995
Improving identification of and intervention for alcoholismP S Mehler, M D McClellan, D Lezotte, et al.
Kidney International|May 1, 1990
Intra- and extracellular proteins in human normal and polycystic kidney epithelial cellsY Granot, V Van Putten, J Przekwas, et al.
Journal of Medical Genetics|November 1, 1990
Exclusion of autosomal dominant polycystic kidney disease type II (ADPKD2) from 160 cM of chromosome 1S Kumar, W J Kimberling, P A Gabow, et al.
Annals of Internal Medicine|June 1, 1981
Syndromes of toluene sniffing in adultsH Z Streicher, P A Gabow, A H Moss, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 16, 1999
Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal diseaseC K Sharp, B E Zeligman, A M Johnson, et al.
Pageof 9